RU2017144232A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2017144232A3 RU2017144232A3 RU2017144232A RU2017144232A RU2017144232A3 RU 2017144232 A3 RU2017144232 A3 RU 2017144232A3 RU 2017144232 A RU2017144232 A RU 2017144232A RU 2017144232 A RU2017144232 A RU 2017144232A RU 2017144232 A3 RU2017144232 A3 RU 2017144232A3
- Authority
- RU
- Russia
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4713—Plasma globulins, lactoglobulin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4745—Insulin-like growth factor binding protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562182349P | 2015-06-19 | 2015-06-19 | |
US62/182,349 | 2015-06-19 | ||
US201562387420P | 2015-12-24 | 2015-12-24 | |
US62/387,420 | 2015-12-24 | ||
US201662290796P | 2016-02-03 | 2016-02-03 | |
US62/290,796 | 2016-02-03 | ||
PCT/US2016/038198 WO2016205723A2 (en) | 2015-06-19 | 2016-06-17 | Biomarker pairs for predicting preterm birth |
Publications (3)
Publication Number | Publication Date |
---|---|
RU2017144232A RU2017144232A (ru) | 2019-07-19 |
RU2017144232A3 true RU2017144232A3 (ru) | 2019-12-24 |
RU2724013C2 RU2724013C2 (ru) | 2020-06-18 |
Family
ID=57546535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2017144232A RU2724013C2 (ru) | 2015-06-19 | 2016-06-17 | Пары биологических маркеров для предсказания преждевременных родов |
Country Status (14)
Country | Link |
---|---|
US (3) | US10392665B2 (ru) |
EP (2) | EP3311158B1 (ru) |
JP (4) | JP6840391B2 (ru) |
KR (1) | KR20180029046A (ru) |
CN (2) | CN108450003B (ru) |
AU (2) | AU2016279002B2 (ru) |
BR (1) | BR112017027528A2 (ru) |
CA (1) | CA2990000A1 (ru) |
ES (1) | ES2955883T3 (ru) |
HK (1) | HK1254669A1 (ru) |
IL (1) | IL256399B (ru) |
PL (1) | PL3311158T3 (ru) |
RU (1) | RU2724013C2 (ru) |
WO (1) | WO2016205723A2 (ru) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10928402B2 (en) | 2012-12-28 | 2021-02-23 | Nx Prenatal Inc. | Treatment of spontaneous preterm birth |
US20140296108A1 (en) * | 2013-03-15 | 2014-10-02 | Sera Prognostics, Inc. | Biomarkers and methods for predicting preeclampsia |
ES2955883T3 (es) | 2015-06-19 | 2023-12-07 | Sera Prognostics Inc | Pares de biomarcadores para la predicción del parto prematuro |
CN109072479A (zh) | 2015-12-04 | 2018-12-21 | Nx产前公司 | 使用循环微粒对自发性早产风险进行分层 |
WO2018027160A1 (en) * | 2016-08-05 | 2018-02-08 | Sera Prognostics, Inc. | Biomarkers for predicting preterm birth in a pregnant female exposed to progestogens |
WO2018027171A1 (en) * | 2016-08-05 | 2018-02-08 | Sera Prognostics, Inc. | Biomarkers for predicting preterm birth due to preterm premature rupture of membranes versus idiopathic spontaneous labor |
WO2018071845A1 (en) * | 2016-10-13 | 2018-04-19 | Krishnamurti Tamar Priya | A structured medical data classification system for monitoring and remediating treatment risks |
JP2018140172A (ja) * | 2017-02-28 | 2018-09-13 | 株式会社Nttドコモ | データ収集装置及びデータ収集方法 |
WO2019036032A1 (en) * | 2017-08-18 | 2019-02-21 | Sera Prognostics, Inc | PREGNANCY CLOCK PROTEINS FOR PREDICTING THE DATE AND MOMENT OF BIRTH |
KR20200140797A (ko) * | 2018-01-31 | 2020-12-16 | 엔엑스 프리네이탈 인코포레이티드 | 자연 조산의 위험을 계층화하기 위한 순환 미세입자의 용도 |
SG11202007319SA (en) * | 2018-01-31 | 2020-08-28 | Nx Prenatal Inc | Methods of early prediction and prevention of preeclampsia utilizing circulating microparticle-associated biomarkers |
WO2020201521A1 (en) * | 2019-04-04 | 2020-10-08 | Carmentix Pte. Ltd. | Biomarker pairs of preterm birth |
US20220170941A1 (en) * | 2019-04-04 | 2022-06-02 | Carmentix Pte. Ltd. | Biomarker Pairs of Preterm Birth |
EP3786977A1 (de) * | 2019-08-29 | 2021-03-03 | WPmed GbR | Computerimplementiertes verfahren und elektronisches system zur prognose eines entbindungszeitpunkts |
EP4103948A1 (en) * | 2020-02-10 | 2022-12-21 | SomaLogic Operating Co., Inc. | Nonalcoholic steatohepatitis (nash) biomarkers and uses thereof |
WO2022034118A1 (en) | 2020-08-11 | 2022-02-17 | University College Cork - National University Of Ireland, Cork | A method of predicting the risk of spontaneous pre-term birth (sptb) |
CN112126683A (zh) * | 2020-08-31 | 2020-12-25 | 中山大学 | 用于迟发型子痫前期诊断的标志物 |
US20230101470A1 (en) * | 2020-10-27 | 2023-03-30 | Lipocine Inc. | Hydroxyprogesterone Caproate Compositions and Methods of Use in Preventing Preterm Birth |
CN112730692B (zh) * | 2021-01-08 | 2022-11-29 | 首都医科大学附属北京朝阳医院 | 用于预测胎膜早破的生物标记物和方法 |
CN112899360A (zh) * | 2021-02-02 | 2021-06-04 | 北京航空航天大学 | 一种检测特雷彻·柯林斯综合征发生概率的组合物的应用方法 |
CN113223714B (zh) * | 2021-05-11 | 2022-07-05 | 吉林大学 | 一种用于预测子痫前期风险的基因组合、子痫前期风险预测模型及其构建方法 |
CA3220282A1 (en) * | 2021-05-21 | 2022-11-24 | Sera Prognostics, Inc. | Biomarker pairs and triplets for predicting preterm birth |
CN113933516A (zh) * | 2021-09-06 | 2022-01-14 | 山东省妇幼保健院 | 早产潜在预测标志物筛选方法、早产检测试剂盒及其用途 |
WO2023110832A1 (en) | 2021-12-13 | 2023-06-22 | UNIVERSITé LAVAL | Biomarkers for the prediction of preterm birth |
Family Cites Families (97)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
US5130238A (en) | 1988-06-24 | 1992-07-14 | Cangene Corporation | Enhanced nucleic acid amplification process |
ATE141956T1 (de) | 1989-07-11 | 1996-09-15 | Gen Probe Inc | Verfahren zur vervielfältigung von nukleinsäuresequenzen |
CA2020958C (en) | 1989-07-11 | 2005-01-11 | Daniel L. Kacian | Nucleic acid sequence amplification methods |
AU7674591A (en) | 1990-04-12 | 1991-11-11 | Adeza Biomedical Corporation | Pregnancy induced hypertension and eclampsia immunoassay and reagents |
US5455166A (en) | 1991-01-31 | 1995-10-03 | Becton, Dickinson And Company | Strand displacement amplification |
EP0642667B1 (en) | 1991-11-04 | 2001-01-10 | Adeza Biomedical Corporation | Screening method for identifying women at increased risk for preterm delivery |
US5270184A (en) | 1991-11-19 | 1993-12-14 | Becton, Dickinson And Company | Nucleic acid target generation |
US5648211A (en) | 1994-04-18 | 1997-07-15 | Becton, Dickinson And Company | Strand displacement amplification using thermophilic enzymes |
US6678669B2 (en) | 1996-02-09 | 2004-01-13 | Adeza Biomedical Corporation | Method for selecting medical and biochemical diagnostic tests using neural network-related applications |
HUP0102907A1 (hu) | 1996-09-20 | 2004-05-28 | Atherogenics Inc. | Gyulladásos rendellenességek diagnosztizálása és mediátorai |
AU2001278684A1 (en) | 2000-08-09 | 2002-02-18 | Maruho Co., Ltd | Protein induced by homogeneous blood transfusion and dna encoding the same |
GB0026823D0 (en) | 2000-11-02 | 2000-12-20 | King S College London | Diagnosis of pre-eclampsia |
EP1364069B1 (en) | 2001-03-01 | 2009-04-22 | Epigenomics AG | Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes |
AU2002251366A1 (en) | 2001-05-02 | 2002-11-11 | Oxford Glycosciences (Uk) Ltd | Proteins, genes and their use for diagnosis and treatment of breast cancer |
US7435419B2 (en) | 2002-07-19 | 2008-10-14 | Beth Israel Deaconess Medical Center | Methods of diagnosing and treating pre-eclampsia or eclampsia |
DK1540010T3 (da) | 2002-08-06 | 2010-07-26 | Univ Johns Hopkins | Anvendelse af biomarkører til påvisning af ovariecancer |
AU2003290775A1 (en) | 2002-11-14 | 2004-06-03 | Ciphergen Biosystems, Inc. | Biomarkers for intra-amniotic inflammation |
US7541182B2 (en) | 2003-02-13 | 2009-06-02 | Yale University | In vitro test to detect risk of preeclampsia |
US8068990B2 (en) | 2003-03-25 | 2011-11-29 | Hologic, Inc. | Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids |
US7191068B2 (en) | 2003-03-25 | 2007-03-13 | Proteogenix, Inc. | Proteomic analysis of biological fluids |
US20080227125A1 (en) | 2003-07-15 | 2008-09-18 | Guilaine Argoud-Puy | Secreted Polypeptide Species Reduced in Cardiovascular Disorders |
WO2005017192A2 (en) | 2003-08-14 | 2005-02-24 | The General Hospital Corporation | Screening for gestational disorders |
US20050043640A1 (en) | 2003-08-21 | 2005-02-24 | Chang Alexander C. | Remote electrocardiogram for early detection of coronary heart disease |
EP1664797B1 (en) * | 2003-09-23 | 2015-11-11 | The General Hospital Corporation | Screening for preeclampsia |
US20050233400A1 (en) | 2004-03-03 | 2005-10-20 | Weiner Carl P | Proteomic method for predicting success of rescue cerclage |
TW200600785A (en) | 2004-03-23 | 2006-01-01 | Oncotherapy Science Inc | Method for diagnosing non-small cell lung cancer |
DE602005026730D1 (de) | 2004-08-27 | 2011-04-14 | Gen Probe Inc | Einfach-Primernukleinsäuren-Erweiterungsverfahren |
US20080090759A1 (en) | 2004-08-30 | 2008-04-17 | Robert Kokenyesi | Methods and kits for predicting risk for preterm labor |
WO2006029838A2 (en) | 2004-09-14 | 2006-03-23 | Geneprot Inc. | Secreted polypeptide species involved in alzheimer’s disease |
CN101437959A (zh) | 2004-09-20 | 2009-05-20 | 普罗特奥格尼克斯公司 | 诊断胎儿非整倍体 |
EP1836496A2 (en) | 2004-11-08 | 2007-09-26 | Nanobac Life Sciences | Methods and compositions for protein-hydroxy apatite complexes and their application in testing and modulating immunological system including a novel in vitro test for the detection of antibodies against calcium binding protein-hydroxy apatite complexes |
US7955805B2 (en) | 2004-12-15 | 2011-06-07 | Beth Israel Deaconess Medical Center | Nucleic acids and polypeptides useful for diagnosing complications of pregnancy |
CA2528531A1 (en) | 2005-01-06 | 2006-07-06 | Mount Sinai Hospital | Markers of pre-term labor |
CA2593184A1 (en) | 2005-01-06 | 2006-07-13 | Eastern Virginia Medical School | Apolipoprotein a-ii isoform as a biomarker for prostate cancer |
US7662570B2 (en) | 2005-01-26 | 2010-02-16 | The Trustees Of The University Of Pennsylvania | Labor biomarkers, methods comprising same, and methods targeting same |
CA2602088C (en) | 2005-03-11 | 2021-07-27 | Ciphergen Biosystems, Inc. | Biomarkers for ovarian cancer and endometrial cancer |
WO2007022248A2 (en) | 2005-08-16 | 2007-02-22 | Sloan Kettering Institute For Cancer Research | Methods of detection of cancer using peptide profiles |
DK1929297T3 (da) | 2005-09-29 | 2013-03-04 | Caprion Proteomics Usa Llc | Biomarkører for dissemineret sklerose og fremgangsmåder til anvendelse heraf |
US8263342B2 (en) | 2005-10-27 | 2012-09-11 | Yale University | Urinary proteomic biomarker patterns in preeclampsia |
US20070111326A1 (en) | 2005-11-14 | 2007-05-17 | Abbott Laboratories | Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia |
US7790463B2 (en) | 2006-02-02 | 2010-09-07 | Yale University | Methods of determining whether a pregnant woman is at risk of developing preeclampsia |
WO2007090230A1 (en) | 2006-02-06 | 2007-08-16 | Pacific Biotech Pty Ltd | Method related to gestation periods |
GB0605950D0 (en) | 2006-03-24 | 2006-05-03 | Jopejo Ltd | Device for prediction of human or other mammalian labour onset |
EP2924440A3 (en) | 2006-06-07 | 2016-03-09 | Health Diagnostic Laboratory, Inc. | Markers associated with arteriovascular events and methods of use thereof |
WO2008021115A2 (en) | 2006-08-14 | 2008-02-21 | The Brigham And Women's Hospital, Inc. | Diagnostic tests using gene expression ratios |
EP1914548A1 (en) | 2006-10-20 | 2008-04-23 | The University Of Newcastle Research Associates Limited | Method for identifying women with an increased risk of preterm delivery |
EP1914552A1 (en) | 2006-10-20 | 2008-04-23 | The University Of Newcastle Research Associates Limited | Method for identifying women with an increased risk of pre-eclampsia |
US20100137263A1 (en) | 2006-10-20 | 2010-06-03 | Newcastle Innovation Limited | Assay for the detection of biomarkers associated with pregnancy related conditions |
EP1914553A1 (en) | 2006-10-20 | 2008-04-23 | The University Of Newcastle Research Associates Limited | Method for identifying women with an increased risk of foetal growth retardation |
US20100143949A1 (en) | 2006-10-31 | 2010-06-10 | George Mason Intellectual Properties, Inc. | Biomarkers for colorectal cancer |
CA2668640A1 (en) | 2006-11-01 | 2008-05-29 | George Mason Intellectual Properties, Inc. | Biomarkers for neurological conditions |
AU2007338634A1 (en) | 2006-12-26 | 2008-07-03 | Brigham Young University | Serum proteomics system and associated methods |
WO2008085024A1 (en) | 2007-01-12 | 2008-07-17 | Erasmus University Medical Center Rotterdam | Identification and detection of peptides relating to specific disorders |
WO2008093318A1 (en) | 2007-02-01 | 2008-08-07 | Diagnostic Technologies Ltd. | Method for determining preeclampsia risk |
US20080233583A1 (en) | 2007-02-20 | 2008-09-25 | Regents Of The University Of California | Biomarkers for preeclampsia |
GB0704764D0 (en) | 2007-03-12 | 2007-04-18 | Electrophoretics Ltd | Isobarically labelled reagents and methods of their use |
WO2008121340A1 (en) | 2007-03-28 | 2008-10-09 | Vermillion, Inc. | Methods for diagnosing ovarian cancer |
CN101680884A (zh) | 2007-05-05 | 2010-03-24 | 西安大略大学 | 检测先兆子痫的方法 |
WO2008146100A1 (en) | 2007-06-01 | 2008-12-04 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for absolute quantification of polypeptides |
US10247736B2 (en) | 2007-07-20 | 2019-04-02 | Brigham Young University | Identification and quantification of biomarkers for evaluating the risk of preterm birth |
GB0724735D0 (en) | 2007-12-19 | 2008-01-30 | Psynova Neurotech Ltd | Methods and biomarkers for diagnosing and monitoring psychotic disorders |
US20100016173A1 (en) | 2008-01-30 | 2010-01-21 | Proteogenix, Inc. | Maternal serum biomarkers for detection of pre-eclampsia |
WO2009097579A1 (en) | 2008-01-30 | 2009-08-06 | Proteogenix, Inc. | Gestational age dependent proteomic changes of human maternal serum for monitoring maternal and fetal health |
WO2009108073A1 (en) * | 2008-02-28 | 2009-09-03 | Auckland Uniservices Limited | Biomarkers for prediction of preeclampsia and/or cardiovascular disease |
EP2283153A4 (en) | 2008-04-09 | 2011-09-14 | Univ British Columbia | METHODS OF DIAGNOSING THE ACUTE REJECTION OF A CARDIAC ALLOGRAFT |
AU2009262271A1 (en) | 2008-06-25 | 2009-12-30 | Brigham Young University | Identifying and quantifying biomarkers associated with preeclampsia |
US20110256560A1 (en) | 2008-10-20 | 2011-10-20 | University Health Network | Methods and compositions for the detection of ovarian cancer |
US20100216250A1 (en) | 2009-02-20 | 2010-08-26 | Lopez Mary Frances | Methods for Predicting Trisomy 21 in a Fetus |
WO2010099211A2 (en) | 2009-02-27 | 2010-09-02 | University Of Utah Research Foundation | Compositions and methods for diagnosing and preventing spontaneous preterm birth |
US20120149041A1 (en) | 2009-08-20 | 2012-06-14 | University Of Utah Research Foundation | Identification and quantification of biomarkers for evaluating the risk of preterm birth |
WO2011053831A1 (en) | 2009-10-30 | 2011-05-05 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
GB0922240D0 (en) | 2009-12-21 | 2010-02-03 | Cambridge Entpr Ltd | Biomarkers |
WO2011094535A2 (en) | 2010-01-28 | 2011-08-04 | The Board Of Trustees Of The Leland Stanford Junior University | Biomarkers of aging for detection and treatment of disorders |
TWI390204B (zh) | 2010-02-11 | 2013-03-21 | Univ Chang Gung | Biomarker of bladder cancer and its detection method |
AU2011217734B2 (en) | 2010-02-16 | 2016-08-11 | The University Of Newcastle | Protein biomarkers for obstructive airways diseases |
US9465039B2 (en) | 2010-08-06 | 2016-10-11 | Mycartis Nv | Perlecan as a biomarker for renal dysfunction |
CN102445534A (zh) * | 2010-10-15 | 2012-05-09 | 无锡市凯奥善生物医药科技有限公司 | 一种孕妇早产及胎膜早破联检试剂盒 |
US20120190561A1 (en) | 2010-11-15 | 2012-07-26 | Ludwig Wildt | Means and methods for diagnosing endometriosis |
EP2673644B1 (en) * | 2011-02-11 | 2016-02-10 | Exagen Diagnostics, Inc. | Methods for diagnosing systemic lupus erythematosus |
AU2012267884A1 (en) * | 2011-06-07 | 2014-01-23 | Caris Life Sciences Switzerland Holdings Gmbh | Circulating biomarkers for cancer |
RU2486519C1 (ru) * | 2011-11-15 | 2013-06-27 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Российский национальный исследовательский медицинский университет им. Н.И. Пирогова" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО РНИМУ им. Н.И. Пирогова Минздравсоцразви | Способ прогнозирования преждевременных родов и внутриутробного инфицирования плода |
US20130130278A1 (en) * | 2011-11-22 | 2013-05-23 | Ottawa Hospital Research Institute | Detection of risk for pregnancy-related medical conditions |
WO2013081721A1 (en) | 2011-11-30 | 2013-06-06 | Battelle Memorial Institute | Biomarkers for lymphoma |
WO2014066568A1 (en) | 2012-10-24 | 2014-05-01 | Winthrop-University Hospital | Non-invasive biomarker to identify subjects at risk of preterm delivery |
WO2014089124A1 (en) * | 2012-12-03 | 2014-06-12 | Cenexys, Inc. | Immunogenic compositions for inducing an immune response for elimination of senescent cells |
US20160003837A1 (en) | 2013-01-08 | 2016-01-07 | Duke University | Biomarkers for the prediction of preterm birth |
US20140296108A1 (en) | 2013-03-15 | 2014-10-02 | Sera Prognostics, Inc. | Biomarkers and methods for predicting preeclampsia |
JP2016518589A (ja) | 2013-03-15 | 2016-06-23 | セラ プログノスティックス, インコーポレイテッド | 早産を予測するためのバイオマーカーおよび方法 |
US20140287948A1 (en) | 2013-03-15 | 2014-09-25 | Sera Prognostics, Inc. | Biomarkers and methods for predicting preterm birth |
ES2955883T3 (es) | 2015-06-19 | 2023-12-07 | Sera Prognostics Inc | Pares de biomarcadores para la predicción del parto prematuro |
WO2018027171A1 (en) | 2016-08-05 | 2018-02-08 | Sera Prognostics, Inc. | Biomarkers for predicting preterm birth due to preterm premature rupture of membranes versus idiopathic spontaneous labor |
WO2018027160A1 (en) | 2016-08-05 | 2018-02-08 | Sera Prognostics, Inc. | Biomarkers for predicting preterm birth in a pregnant female exposed to progestogens |
WO2019036032A1 (en) | 2017-08-18 | 2019-02-21 | Sera Prognostics, Inc | PREGNANCY CLOCK PROTEINS FOR PREDICTING THE DATE AND MOMENT OF BIRTH |
-
2016
- 2016-06-17 ES ES16812566T patent/ES2955883T3/es active Active
- 2016-06-17 CN CN201680048762.6A patent/CN108450003B/zh active Active
- 2016-06-17 CN CN202210279464.5A patent/CN115015552A/zh active Pending
- 2016-06-17 RU RU2017144232A patent/RU2724013C2/ru active
- 2016-06-17 IL IL256399A patent/IL256399B/en unknown
- 2016-06-17 PL PL16812566.4T patent/PL3311158T3/pl unknown
- 2016-06-17 AU AU2016279002A patent/AU2016279002B2/en active Active
- 2016-06-17 KR KR1020187001679A patent/KR20180029046A/ko not_active Application Discontinuation
- 2016-06-17 EP EP16812566.4A patent/EP3311158B1/en active Active
- 2016-06-17 BR BR112017027528-7A patent/BR112017027528A2/pt unknown
- 2016-06-17 CA CA2990000A patent/CA2990000A1/en active Pending
- 2016-06-17 JP JP2017565752A patent/JP6840391B2/ja active Active
- 2016-06-17 WO PCT/US2016/038198 patent/WO2016205723A2/en active Application Filing
- 2016-06-17 US US15/186,322 patent/US10392665B2/en active Active
- 2016-06-17 EP EP23193775.6A patent/EP4321626A3/en active Pending
-
2018
- 2018-10-24 HK HK18113650.4A patent/HK1254669A1/zh unknown
-
2019
- 2019-04-10 US US16/380,938 patent/US10961584B2/en active Active
-
2020
- 2020-07-03 JP JP2020115551A patent/JP2020165993A/ja not_active Withdrawn
-
2021
- 2021-03-01 US US17/189,048 patent/US11987846B2/en active Active
-
2022
- 2022-08-04 JP JP2022124685A patent/JP7385951B2/ja active Active
- 2022-09-05 JP JP2022140667A patent/JP2022173239A/ja active Pending
- 2022-09-27 AU AU2022241477A patent/AU2022241477A1/en active Pending